Study of the blood glucose level reduction effects by ingestion of botanical extract-containing foods.

The verification study to evaluate the reduction effects of blood glucose level by ingestion of botanical extract-containing foods in healthy adults with a higher fasting blood glucose level. - The verification study to evaluate the reduction effects of blood glucose level by ingestion of botanical extract-containing foods.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042007

Enrollment

Registered

2020-10-05

Start date

2020-10-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Interventions

12-week intake of the test food 12-week intake of the placebo food

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Healthy males and females from 20 to 64 years of age 2) Fasting blood glucose level from 90 mg/dL to 125 mg/dL

Exclusion criteria

Exclusion criteria: 1) Subjects who have a habit of ingesting botanical extract-containing food. 2) Subjects having possibilities for emerging allergy related to the study. 3) Subjects who routinely take foods or medicines affecting the test result. 4) Subjects who have a disease requiring regular medication. 5) Subjects who are under treatment or have a history of serious disease (e.g. pancreatic disease, endocrine disease, liver disease, gastrectomy, kidney disease, heart disease or cancer). 6) Ineligible subjects with abnormal laboratory value or cardiopulmonary function. 7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. 8) Subjects who have habits affecting research results, such as doing shift work day and night, or Subjects who have a plan that affect research results such as day and night shift work and overseas. 9) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. 10) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. 12) Subjects judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose level	—

Secondary

Measure	Time frame
Postprandial blood glucose level, Adiponectin, Weight, Uric acid, HbA1c	—

Countries

Japan

Contacts

Public ContactKaori Yoshimura

TTC Co., Ltd. Clinical Research Planning Department

k.ishida@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026